Antibiotice (BSE:ATB) Cash Flow from Operations : lei127.8 Mil (TTM As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Antibiotice Cash Flow from Operations?

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the three months ended in Mar. 2024, Antibiotice's Cash Receipts from Operating Activities was lei0.0 Mil. Its Cash Payments was lei0.0 Mil. Its Dividends Paid was lei0.0 Mil. Its Dividends Received was lei0.0 Mil. Its Interest Paid was lei0.0 Mil. Its Interest Received was lei0.0 Mil. Its Taxes Refund Paid was lei0.0 Mil. And its Cash Flow from Others was lei0.0 Mil. In all, Antibiotice's Cash Flow from Operations for the three months ended in Mar. 2024 was lei1.8 Mil.

Antibiotice Cash Flow from Operations Historical Data

The historical data trend for Antibiotice's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antibiotice Cash Flow from Operations Chart

Antibiotice Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow from Operations

Get a 7-Day Free Trial

20.63

94.05

44.44

115.66

122.46

Antibiotice Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash Flow from Operations	Get a 7-Day Free Trial															-3.49	36.85	28.17	60.93	1.81

Antibiotice Cash Flow from Operations Calculation

Antibiotice's Cash Flow from Operations for the fiscal year that ended in Dec. 2023 is calculated as:

	Cash Flow from Operations		(A: Dec. 2023 )
=	Cash Receipts from Operating Activities	+	Cash Payments	+	Dividends Paid	+	Dividends Received
=	0	+	0	+	0	+	0
+	Interest Paid	+	Interest Received	+	Taxes Refund Paid	+	Cash Flow from Others
+	0	+	0	+	0	+	0
=	0.0

Antibiotice's Cash Flow from Operations for the quarter that ended in Mar. 2024 is:

	Cash Flow from Operations		(Q: Mar. 2024 )
=	Cash Receipts from Operating Activities	+	Cash Payments	+	Dividends Paid	+	Dividends Received
=	0	+	0	+	0	+	0
+	Interest Paid	+	Interest Received	+	Taxes Refund Paid	+	Cash Flow from Others
+	0	+	0	+	0	+	0
=	0.0

Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was lei127.8 Mil.

Antibiotice (BSE:ATB) Cash Flow from Operations Explanation

For non-financial companies reported in direct method, cash flow from operations contains eight items:

1. Cash Receipts from Operating Activities:
Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

Antibiotice's cash receipts from operating activities for the three months ended in Mar. 2024 was lei0.0 Mil.

2. Cash Payments:
It represents cash flow paid from operating activities in the direct cash flow method.